Zymewire Blog

Best practice guides, webinars, product info and podcasts.

OUR LATEST

Zymewire Blog

Reach your prospects the first time: Announcing improvements to Contact Search

14 Feb, 2022
Laser-focused outreach outperforms generic messages and mass emails. That’s the guiding principle behind our update to Contact Search, released today. Read More

Recent Posts

What’s the deal with NLP?
What’s the deal with NLP?
31 Mar, 2022
Industry Articles
by Ian Hamilton-Burge, Director of Customer Solutions

Machine learning. Artificial intelligence. Predictive analytics.      

Read More
Scott’s Sales Tales: What Can Sales Pros Learn from a Hot Dog Eating Champ?
Scott’s Sales Tales: What Can Sales Pros Learn from a Hot Dog Eating Champ?
31 Mar, 2022
Sales
by Scott Ballenger

For those that are new to the “Sales Tales,” we launched a series of posts here on the Zymewire blog that capture some of my favorite sales ...

Read More
How the Heck to Find Your Way Around the Cell and Gene Therapy Space
How the Heck to Find Your Way Around the Cell and Gene Therapy Space
31 Mar, 2022
Industry Articles
by Team Zymewire

We know that the cell and gene therapy space is unique – and can be uniquely challenging to navigate, with specific quirks and nuances.

Read More
On the Virtual Road: Sales Tales with Scott Ballenger - Positioning
On the Virtual Road: Sales Tales with Scott Ballenger - Positioning
31 Mar, 2022
Sales
by Scott Ballenger

A few weeks ago, we launched a series of posts here on the Zymewire blog that encapsulate some of my favorite sales parables. In a ...

Read More
The Latest on Return to Business Travel
The Latest on Return to Business Travel
31 Mar, 2022
Industry Articles
by Team Zymewire

We had all hoped for far more certainty around travel this coming fall – but as the delta variant continues to wreak havoc around the ...

Read More
On the Virtual Road: Sales Tales with Scott Ballenger - One egg or two?
On the Virtual Road: Sales Tales with Scott Ballenger - One egg or two?
31 Mar, 2022
Sales
by Scott Ballenger

The pandemic has cost us many things, including, for too many of us, the ability to connect with our colleagues in person. At Zymewire, we ...

Read More
Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.
Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.
31 Mar, 2022
Industry Articles
by Team Zymewire

Recently, Zymewire’s Scott Ballenger had an opportunity to sit down with Stefanie Kuhner, an executive in the procurement department from ...

Read More
11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies
11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies
31 Mar, 2022
Industry Articles
by Ian Hamilton-Burge, Director of Customer Solutions

During our ongoing conversations with clients here at Zymewire, it became clear that cell and gene therapy companies were really heating up ...

Read More
Discovering Stealth Companies: Neuway Pharma from Bonn, Germany
Discovering Stealth Companies: Neuway Pharma from Bonn, Germany
31 Mar, 2022
Industry Articles
by Sara El-Talmas, Zymewire

We’re looking at Neuway Pharma, a Europe-based biotech startup,  in this edition of Sponsor Atlas series.  This branch of the blog focuses ...

Read More
Selling to Biotech After the COVID Cliff
Selling to Biotech After the COVID Cliff
31 Mar, 2022
Zymewire News
by Casey Enders

Are you wondering how the pandemic will change the biotech landscape and your prospecting work? We were, too – so we dug into the data and ...

Read More
Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics
Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup
Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup
31 Mar, 2022
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup
Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup
31 Mar, 2022
Industry Articles
by Amarpreet Singh

In this edition of Sponsor Atlas: Discovering Biotech Startups, we’re looking at Braizon Therapeutics (Braizon). We will give a business ...

Read More
Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup
Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup
31 Mar, 2022
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Sulfateq BV: A Map for Selling to this European Biotech Startup
Sulfateq BV: A Map for Selling to this European Biotech Startup
31 Mar, 2022
Industry Articles
by Amarpreet Singh

In this edition of Sponsor Atlas: Discovering Biotech Startups, we are looking at Sulfateq BV (Sulfateq), exploring the current affairs and ...

Read More
Montisera: A Map for selling to this emerging European Biotech
Montisera: A Map for selling to this emerging European Biotech
31 Mar, 2022
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup
Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup
31 Mar, 2022
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
CPhI Festival of Pharma
CPhI Festival of Pharma
31 Mar, 2022
Racolta
by Amarpreet Singh

After many discussions with key partners and industry stakeholders, the annual CPhI Worldwide (in-person) event is now confirmed to return ...

Read More
All About AbbVie: A map for Selling to AbbVie
All About AbbVie: A map for Selling to AbbVie
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Discovering Biotech Startups: A map for Selling to Geneos Therapeutics
Discovering Biotech Startups: A map for Selling to Geneos Therapeutics
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Blueprint to Biogen: A map for Selling to Biogen
Blueprint to Biogen: A map for Selling to Biogen
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Discovering Biotech Startups: A map for Selling to Pyxis Oncology
Discovering Biotech Startups: A map for Selling to Pyxis Oncology
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Felix Biotechnology
Discovering Biotech Startups: A map for Selling to Felix Biotechnology
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Sales Intelligence Products: Things to Consider for Your Team
Sales Intelligence Products: Things to Consider for Your Team
31 Mar, 2022
Industry Articles
by Sean Cannon

In today’s world, many providers are claiming to be sales intelligence solutions. This statement is remarkably convoluted, as the category ...

Read More
Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup
Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup
31 Mar, 2022
Industry Articles
by Amarpreet Singh

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics
Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Symbiotica
Discovering Biotech Startups: A map for Selling to Symbiotica
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
DIA Global Annual Meeting 2020
DIA Global Annual Meeting 2020
31 Mar, 2022
Racolta
by David Wilkerson

In light of the recent pandemic that has spread throughout the world, it is with great excitement to know that much of the invaluable ...

Read More
Discovering Biotech Startups: A map for Selling to Snap Bio
Discovering Biotech Startups: A map for Selling to Snap Bio
31 Mar, 2022
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Discovering Biotech Startups: A map for Selling to Intrepida Bio
Discovering Biotech Startups: A map for Selling to Intrepida Bio
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Alaya Bioscience
Discovering Biotech Startups: A map for Selling to Alaya Bioscience
31 Mar, 2022
Industry Articles
by David Wilkerson

We are moving right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Read More
Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals
Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
What do big pharma companies spend on research & development?
What do big pharma companies spend on research & development?
31 Mar, 2022
Zymewire News
by Sean Cannon

We've been working hard on a new report, and today we're happy to share that it is now available through Outsourcing-Pharma! Our inaugural ...

Read More
Zymewire Launches Directory of Drug Development Experts with Services Available to Fight COVID-19
Zymewire Launches Directory of Drug Development Experts with Services Available to Fight COVID-19
31 Mar, 2022
Company News
by Team Zymewire

In these unprecedented times, the Zymewire team has been thinking deeply about ways in which we can contribute to the global fight against ...

Read More
Guide to Gilead: A map for Selling to Gilead Sciences
Guide to Gilead: A map for Selling to Gilead Sciences
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Racolta: Cancelled and Postponed Conferences between March 15 - April 11 2020
Racolta: Cancelled and Postponed Conferences between March 15 - April 11 2020
31 Mar, 2022
Racolta
by Racolta

Due to recent circumstances, the following conferences have released statements advising of changes to scheduled events. Please see ...

Read More
Decisions, Decisions: A map for Selling to Novartis
Decisions, Decisions: A map for Selling to Novartis
31 Mar, 2022
Industry Articles
by Xhermi Trimi

As a large, complex, multinational company, it isn’t all that obvious which decisions are made at which Novartis sites around the world. ...

Read More
DCAT Week 2020
DCAT Week 2020
31 Mar, 2022
Racolta
by David Wilkerson

Update: Unfortunately, due to the current COVID-19 situation, DCAT Week 2020 has officially been cancelled. At the time of publish, there ...

Read More
Discovering Biotech Startups: A map for Selling to Soteria Biotherapeutics
Discovering Biotech Startups: A map for Selling to Soteria Biotherapeutics
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb
Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb
31 Mar, 2022
Industry Articles
by Xhermi Trimi

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're visiting New York City's biopharma behemoth, Bristol-Myers Squibb ...

Read More
Outsourcing in Pharma & Biotech: Shifting to Contract Manufacturing and Development
Outsourcing in Pharma & Biotech: Shifting to Contract Manufacturing and Development
31 Mar, 2022
Industry Articles
by David Wilkerson

As the world’s population ages and healthcare standards continue to rise, the demand for pharmaceutical products has been steadily ...

Read More
Discovering Biotech Startups: A map for Selling to Nitrome Biosciences
Discovering Biotech Startups: A map for Selling to Nitrome Biosciences
31 Mar, 2022
Industry Articles
by David Wilkerson

Welcome to the next edition of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies that are in ...

Read More
Activating Amgen: A map for Selling to Amgen
Activating Amgen: A map for Selling to Amgen
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Amgen Inc. is one of the world’s 10 largest biopharmaceutical companies, founded and headquartered in California, USA. In 2018, Amgen ...

Read More
DIA Europe 2020
DIA Europe 2020
31 Mar, 2022
Racolta
by David Wilkerson

The beautiful city of Brussels, the capital of Belgium, is also known as the capital of Europe. Brussels is well known for being ...

Read More
Outsourcing in Clinical Trials (OCT) West Coast 2020
Outsourcing in Clinical Trials (OCT) West Coast 2020
31 Mar, 2022
Racolta
by David Wilkerson

Offering all of the attractions of most world-class cities, such as gorgeous museums and cosmopolitan restaurants, San Francisco’s location ...

Read More
Finding Pfizer: A map for Selling to Pfizer
Finding Pfizer: A map for Selling to Pfizer
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Pfizer Inc. is a global biopharmaceutical corporation headquartered in New York City, where it was founded in 1849. In 2019, they ranked #1 ...

Read More
Accessing Allergan: A map for Selling to Allergan
Accessing Allergan: A map for Selling to Allergan
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Summit for Clinical Ops Executives (SCOPE) 2020
Summit for Clinical Ops Executives (SCOPE) 2020
31 Mar, 2022
Racolta
by David Wilkerson

Orlando is a city full of wonder and excitement. From visiting Disney’s Magic Kingdom to relaxing in fantastic spa treatments, including a ...

Read More
Mapping Merck: A map for Selling to Merck & Co.
Mapping Merck: A map for Selling to Merck & Co.
31 Mar, 2022
Industry Articles
by Xhermi Trimi

Merck & Co. is an American pharmaceutical company, ranked 4th internationally in the world in terms of 2017 prescription sales [1]. It ...

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.